8-KEarnings & ResultsExhibits & Filings

VERTEX PHARMACEUTICALS INC / MA 8-K Report, Financial Results (Jul 24, 2007)

Filed July 24, 2007For Securities:VRTX

Summary

Vertex Pharmaceuticals Incorporated (VRTX) filed an 8-K on July 24, 2007, to report its consolidated financial results for the quarter ended June 30, 2007. The core of this filing is the attached press release (Exhibit 99.1), which provides details on the company's operational performance and financial condition. Investors should pay close attention to the "Recent Achievements and 2007 Objectives" and the "Special Note Regarding Forward-Looking Statements" sections of the press release, as these are incorporated by reference and deemed filed under Section 18 of the Exchange Act.

Key Highlights

  • 1Vertex Pharmaceuticals reported its financial results for the quarter ended June 30, 2007, via a press release filed as Exhibit 99.1.
  • 2The filing is primarily an announcement of quarterly financial results, with the press release serving as the main informational document.
  • 3Key sections of the press release, specifically 'Recent Achievements and 2007 Objectives' and 'Special Note Regarding Forward-Looking Statements', are formally incorporated by reference into the filing.
  • 4This incorporation means these specific sections are subject to Section 18 of the Securities Exchange Act of 1934, implying potential liability for misstatements or omissions within them.
  • 5The filing itself is a standard Form 8-K, indicating material events or updates for investors.
  • 6Ian F. Smith, Executive Vice President and Chief Financial Officer, signed the filing, attesting to its accuracy on behalf of Vertex Pharmaceuticals.

Frequently Asked Questions

The main purpose of this 8-K filing is to formally report Vertex Pharmaceuticals' consolidated financial results for the quarter ended June 30, 2007, by attaching a press release (Exhibit 99.1) that contains these results.

The sections titled 'Recent Achievements and 2007 Objectives' and 'Special Note Regarding Forward-Looking Statements' from the press release dated July 24, 2007, are deemed 'filed' for purposes of Section 18 of the Exchange Act.

The detailed financial results and updates on recent achievements and objectives are found in the press release, dated July 24, 2007, which is filed as Exhibit 99.1 to this Form 8-K.

When information is incorporated by reference, it is treated as if it were directly included in the SEC filing. For the sections noted, this means they are part of the official disclosure and are subject to the legal standards and liabilities associated with filed documents.